US Food and Drug Administration US FDA has successfully completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Scienc
The US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences API manufacturing facility in Visakhapatnam, Andhra Pradesh, with no observations. Solara confirms compliance with FDA standards. The facility, dedicated to Ibuprofen API production, marks Solara s second successful FDA inspection. The company aims for global market expansion with FDA-approved facilities.
Share Market Highlights 28 March 2024: Indian equity markets end FY24 on a bullish note; Sensex jumps 650 pts, Nifty settles above 22,300 thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.